Zhejiang Beta Pharma betapharma.com.cn


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Beta Pharma is a Chinese biotech company focused on the development of therapies for cancer and inflammatory diseases. In 2011, the company received Chinese FDA approval for its "Class One" new drug Icotinib, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, for non-small cell lung cancer (NSCLC) in China. Icotinib is the first commercialized project in China's "Significant Innovative Drug Development" program. Beta Pharma is headquartered in Hangzhou, with its R&D c...Show all

Beta Pharma is a Chinese biotech company focused on the development of therapies for cancer and inflammatory diseases. In 2011, the company received Chinese FDA approval for its "Class One" new drug Icotinib, a selective epidermal growth factor recep...Show all

Company (Alive / Active)

Phone: 86-0571-8926-6822

Fax:

589 Hongfeng Rd
Yuhang
Hangzhou, 311 100
Zhejiang , China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zhejiang Beta Pharma $0M Jun 11, 2010

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zhejiang Beta Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Lilly Asia VenturesCorporate VentureShanghai, Shanghai, ChinaSeries A
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)